Key facts
- MedVital’s last known valuation is $4.5M (May 2025).
- It has raised $1.1M; the latest was Seed Round ($1.1M) in May 2025.
- Notable investors include Group of Marquee Investors, 4point0 Health Ventures, Alkemi Growth Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for MedVital
- ·The full record, as it builds
Funding rounds
No funding rounds for MedVital are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedVital
Developer of wound therapy products and technologies designed to advance wound care, wound closure, tissue regeneration, and scar management. The company offers advanced Negative Pressure Wound Therapy (NPWT) systems with real-time leakage monitoring, portability and ease of use, enabling both patients and healthcare professionals to experience superior wound care.
- Sector
- Healthcare
- HQ
- Gurugram, India
- Founded
- 2024
- Employees
- 11
- Website
- themedvital.com/
- Ownership
- Privately Held (backing)
MedVital doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedVital shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedVital in its N-PORT filings yet. We sweep new filings monthly.